FR2906466B1 - Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme - Google Patents

Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme

Info

Publication number
FR2906466B1
FR2906466B1 FR0654002A FR0654002A FR2906466B1 FR 2906466 B1 FR2906466 B1 FR 2906466B1 FR 0654002 A FR0654002 A FR 0654002A FR 0654002 A FR0654002 A FR 0654002A FR 2906466 B1 FR2906466 B1 FR 2906466B1
Authority
FR
France
Prior art keywords
man
compounds
treatment
dermatological disorders
milbemycin family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0654002A
Other languages
English (en)
Other versions
FR2906466A1 (fr
Inventor
Alexandre Kaoukhov
Cecile Cousin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0654002A priority Critical patent/FR2906466B1/fr
Priority to EP07823876A priority patent/EP2077833A1/fr
Priority to PCT/FR2007/052041 priority patent/WO2008037936A1/fr
Publication of FR2906466A1 publication Critical patent/FR2906466A1/fr
Application granted granted Critical
Publication of FR2906466B1 publication Critical patent/FR2906466B1/fr
Priority to US12/382,892 priority patent/US20090264516A1/en
Priority to US13/079,993 priority patent/US20120065256A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0654002A 2006-09-28 2006-09-28 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme Expired - Fee Related FR2906466B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0654002A FR2906466B1 (fr) 2006-09-28 2006-09-28 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
EP07823876A EP2077833A1 (fr) 2006-09-28 2007-09-27 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
PCT/FR2007/052041 WO2008037936A1 (fr) 2006-09-28 2007-09-27 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
US12/382,892 US20090264516A1 (en) 2006-09-28 2009-03-26 Milbemycin compounds and treatment of dermatological disorders in humans therewith
US13/079,993 US20120065256A1 (en) 2006-09-28 2011-04-05 Milbemycin compounds and treatment of dermatological disorders in humans therewith

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0654002A FR2906466B1 (fr) 2006-09-28 2006-09-28 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme

Publications (2)

Publication Number Publication Date
FR2906466A1 FR2906466A1 (fr) 2008-04-04
FR2906466B1 true FR2906466B1 (fr) 2008-11-28

Family

ID=37800342

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0654002A Expired - Fee Related FR2906466B1 (fr) 2006-09-28 2006-09-28 Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme

Country Status (4)

Country Link
US (2) US20090264516A1 (fr)
EP (1) EP2077833A1 (fr)
FR (1) FR2906466B1 (fr)
WO (1) WO2008037936A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2942138A1 (fr) * 2009-02-16 2010-08-20 Galderma Res & Dev Association de composes pour le traitement ou la prevention des affections dermatologiques
BR112012009145A2 (pt) * 2009-10-19 2016-08-30 Intervet Int Bv método para o controle simultâneo de parasitas internos e externos em e sobre um animal, formulação micelar aquosa, e, usos de uma formulação micelar aquosa e de uma lactona macrocíclica
EP2886640A1 (fr) 2013-12-18 2015-06-24 Riga Technical University Procédé d'isolation pour milbemycine A3 et A4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6376548B1 (en) * 2000-01-28 2002-04-23 Rohm And Haas Company Enhanced propertied pesticides
US7262214B2 (en) * 2003-02-26 2007-08-28 Merial Limited 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations

Also Published As

Publication number Publication date
US20120065256A1 (en) 2012-03-15
EP2077833A1 (fr) 2009-07-15
FR2906466A1 (fr) 2008-04-04
US20090264516A1 (en) 2009-10-22
WO2008037936A1 (fr) 2008-04-03

Similar Documents

Publication Publication Date Title
IL264736B (en) Pharmaceutical preparations containing zonisamide for use in the treatment of diseases related to Alzheimer's disease
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2906808B1 (fr) Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
WO2007038459A3 (fr) Composes de carboxyamine et leurs methodes d'utilisation
WO2008002621A3 (fr) Effecteurs allostériques positifs du récepteur m1 à base de quinolone à substitution benzyle
EP2268647A4 (fr) Composés et compositions pour la détection et le traitement de la maladie d'alzheimer et des troubles associés
EP2001503A4 (fr) Diagnostic et traitement de la maladie d'alzheimer
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
FR2906131B1 (fr) Ensemble chirurgical de traitement de l'incontinence urinaire chez l'homme
EP2035412A4 (fr) Agonistes du récepteur muscarinique convenant au traitement de la douleur, de la maladie d'alzheimer et de la schizophrénie
IL195431A0 (en) Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
FR2906468B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2896422B1 (fr) Systeme de drainage pour le traitement de l'hydrocephalie
FR2918282B1 (fr) Medicament pour le traitement de la maladie de parkinson
FR2919187B1 (fr) Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2906469B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2906467B1 (fr) Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR2906466B1 (fr) Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR2908658B1 (fr) Composition pour la prevention et/ou le traitement des maladies associees a la surexpression du tnf et/ou de l'il-12
WO2009134668A3 (fr) Modulateurs allostériques positifs pour le récepteur m1 de 4-oxo-1,4-dihydroquinoléine
FR2924593B1 (fr) Plaque osseuse pour le traitement de l'extremite inferieure du cubitus

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140530